Koninklijke Philips NV ADR is a medical devices business based in the US. Koninklijke Philips NV ADR shares (PHG) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $24.09 – a decrease of 4.97% over the previous week. Koninklijke Philips NV ADR employs 66,678 staff and has a trailing 12-month revenue of around $18 billion.
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $24.09 |
|---|---|
| 52-week range | $21.48 - $32.91 |
| 50-day moving average | $25.22 |
| 200-day moving average | $27.39 |
| Wall St. target price | $32.67 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-1.02 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $25.64 from 2025-05-05
| 1 week (2025-04-30) | 1.14% |
|---|---|
| 1 month (2025-04-08) | 18.32% |
| 3 months (2025-02-07) | -6.01% |
| 6 months (2024-11-08) | -3.65% |
| 1 year (2024-05-08) | 1.98% |
|---|---|
| 2 years (2023-05-05) | 30.97% |
| 3 years (2022-05-06) | 11.61% |
| 5 years (2020-05-07) | 36.5152 |
Valuing Koninklijke Philips NV ADR stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Koninklijke Philips NV ADR's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Koninklijke Philips NV ADR's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.3632. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Koninklijke Philips NV ADR's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Koninklijke Philips NV ADR's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.6 billion.
The EBITDA is a measure of a Koninklijke Philips NV ADR's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $18 billion |
|---|---|
| Operating margin TTM | 12.07% |
| Gross profit TTM | $7.8 billion |
| Return on assets TTM | 2.01% |
| Return on equity TTM | -6.98% |
| Profit margin | -3.9% |
| Book value | $12.98 |
| Market Capitalization | $23.7 billion |
TTM: trailing 12 months
Dividend payout ratio: 76.81% of net profits
Recently Koninklijke Philips NV ADR has paid out, on average, around 100% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Koninklijke Philips NV ADR shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In Koninklijke Philips NV ADR's case, that would currently equate to about $N/A per share.
Koninklijke Philips NV ADR's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
Koninklijke Philips NV ADR's most recent dividend payout was on 5 June 2025. The latest dividend was paid out to all shareholders who bought their shares by 12 May 2025 (the "ex-dividend date").
Koninklijke Philips NV ADR's shares were split on a 4:1 basis on 17 April 2000 . So if you had owned 1 share the day before before the split, the next day you'd have owned 4 shares. This wouldn't directly have changed the overall worth of your Koninklijke Philips NV ADR shares – just the quantity. However, indirectly, the new 75% lower share price could have impacted the market appetite for Koninklijke Philips NV ADR shares which in turn could have impacted Koninklijke Philips NV ADR's share price.
Over the last 12 months, Koninklijke Philips NV ADR's shares have ranged in value from as little as $21.4779 up to $32.91. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Koninklijke Philips NV ADR's is 0.888. This would suggest that Koninklijke Philips NV ADR's shares are less volatile than average (for this exchange).
Koninklijke Philips N. V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. It provides diagnostic imaging solutions, includes magnetic resonance imaging; X-ray systems; and computed tomography (CT) systems and software comprising detector-based spectral CT solutions; ultrasound imaging solutions focused on diagnosis, treatment planning and guidance for cardiac, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional X-ray systems and software solutions; and interventional image devices and software to aid in the diagnosis, navigation, treatment, and confirmation in minimally invasive interventional coronary, peripheral vascular, and hearth rhythm management procedures. The company also offers acute patient management solutions; emergency care solutions; patient care management in ambulatory and home care; sleep and respiratory care solutions; and vendor-agnostic software solutions. In addition, it provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental and women's health solutions; and grooming and beauty products and solutions.